Praxis Precision Medicines (NASDAQ:PRAX) used its fourth-quarter and full-year 2025 earnings call to highlight multiple ...
Carol Foro tested positive for a banned substance before her UFC debut, leading to the cancellation of her fight set for ...
That's what the analyst community seems to expect from Viking Therapeutics (NASDAQ: VKTX) in the foreseeable future. The ...
The results of 2 recent clinical trials combining the GLP-1 drug and the biologic reinforce the benefits of treating obesity ...
The Utah Senate on Wednesday passed SB45 to restrict kratom sales, limiting it to specialty shops. A substitute bill by Sen. Mike McKell, R-Spanish Fork, bans kratom in gas stations and raises the ...
Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 10:00 AM ESTCompany ParticipantsNadim Ahmed - ...
Remibrutinib shows significant complete response rates across 3 chronic inducible urticaria subtypes in the phase 3 RemIND trial.
High On Life 2 improves on its predecessor with a skateboard, biting satire, and boundless creativity, but middling combat ...
Appointment is a positive endorsement of NovaBridge's unique hub-and-spoke model and focus on creating shareholder value by accelerating the development of transformative medicines for patients around ...
ImmunityBio IBRX stock: jumped 31% Wednesday after the EU approved ANKTIVA for bladder cancer, now authorized in 33 countries with a 71% clinical response rate.
Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...
15h
Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company") today announced that its wholly owned subsidiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results